tykhr
sign in
free sign up
Johnson & Johnson
Drug Manufacturers - General
Healthcare
JNJ
2.42 B shares
NYSE US
traded
23 Sep 2025
listed
no
open
174.89
52 week high
179.29
high
176.97
52 week low
0.00
low
174.83
growth
8.43 %
previous Close
174.21
P/E ratio
64
market cap
367 B
div yield
0
usd
Mar 2025
qoq
revenue
21.89 B
-2.78 %
net incoming
11.00 B
220.58 %
eps
2.77 %
35.78 %
eps surprise
7.36 %
net profit margin
50.24 %
0.35 %
operating incoming
6.30 B
63.99 %
net change in cash
14.37 B
248.34 %
cash on hand
38.47 B
59.61 %
cost of revenue
7.36 B
3.21 %
top